Wilmott JS, Tawbi H, Engh JA, Amankulor NM, et al. Clinical features associated with outcomes and biomarker analysis of dabrafenib plus trametinib treatment in patients with BRAF-mutant melanoma brain metastases. Clin Cancer Res 2022 Dec 7:CCR-22-2581. doi: 10.1158/1078-0432.CCR-22-2581.
PMID: 36477181